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ABSTRACT: The mechanism of modulation of vanadate inhibition of alkaline phosphatase activity by catalytic 
cofactors has not been fully characterized. We investigated the effect of the interaction of catalytic cofactors (Mg2+ 
and Zn2+) and vanadate (an active site inhibitor) on the rate of hydrolysis of para-nitrophenyl phosphate (pNPP) 
(monoesterase reaction) by calf intestinal alkaline phosphatase (CIAP). The results showed that vanadate 
significantly inhibited ʻcofactor-freeʼ CIAP, and the inhibition was relieved by the presence of the catalytic cofactors 
in the reaction. Our results show that the absence of the cofactors did not significantly alter the Km of the reaction, 
but caused a decrease in the Vmax. Kinetic analyses showed that vanadate inhibited CIAP-catalyzed hydrolysis of 
pNPP by decreasing the Vmax and increasing the Km of the reaction. The presence of cofactors in the reaction 
alleviated the effect of vanadate by increasing the Vmax and decreasing the Km. The activity of the dialyzed CIAP was 
increased by the addition of catalytic cofactors to vanadate-inhibited enzyme. This study provides preliminary data 
that reversible inhibition of CIAP is subject to the influence of catalytic cofactors. Further studies will reveal detailed 
mechanistic aspects of this observation and its significance in the biological system.  
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Phosphoryl transfer reactions are a common theme in 
biological processes. The central roles of nucleic acids, high-
energy nucleotides, and other phosphate containing 
molecules in cellular systems necessitate well-regulated 
mechanisms for controlling the transfer of phosphate groups 
from donor molecules to acceptor molecules. Rate 
enhancement and specificity are key issues in phosphoryl 
transfer reactions that require tight regulations. Frequently, 
metal ion cofactors and inhibitors are participants in 
regulating these key aspects of catalysis. Alkaline 
phosphatase (AP) is a metalloenzyme that catalyses 
phosphoryl transfer reaction and thus a good model for 
studying cofactor-inhibitor interactions in enzyme catalysis. 
The enzyme is comprised of two identical subunits, each of 
which contains two zinc and one magnesium ions (Kim and 
Wyckoff, 1991).  
Alkaline phosphatase exists in organisms of all kinds and 
plays a vital role in survival under phosphate starvation 
(Prada et al., 1996; Zappa et al., 2001; Ayantika and 
Parames, 2007). There is only one Escherichia coli alkaline 
phosphatase (ECAP), but four alkaline phosphatase 
isoenzymes, that have been isolated in humans. In humans, 
three out of four AP isozymes are tissue-specific: one is 
placental (PLAP), the second appears in germ cells (GCAP), 
and the third in the intestine (IAP). They are 90–98% 
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homologous, and their genes are clustered on chromosome 
2q37.1. The fourth, tissue-nonspecific (TNAP), 50% identical 
to the other three, is nonspecific and can be found in bone, 
liver, and kidney (Weiss et al., 1986; Millan and Manes, 
1988; Millan, 2006). Its gene is located on chromosome 
1p34–36 (Greenberg et al., 1990), and mutations in the 
TNAP gene have been associated with hypophosphatasia, a 
rare inherited disorder, characterized by defective bone 
mineralization (Whyte, 1994). Moreover, at least seven 
isoenzymes of intestinal alkaline phosphatase have been 
revealed in bovine intestinal alkaline phosphatase (Manes et 
al., 1998). Alkaline phosphatase is present in both soluble 
and membrane forms, but more than 95% of the intestinal 
isoenzyme is normally associated with the brush border 
membrane (Seetharam et al., 1977; Steven et al., 1981).  
The skeletal isoenzyme of AP has been implicated in matrix 
vesicle-mediated calcification during bone formation and 
phosphate transport (Cyboron et al., 1982). Inorganic 
pyrophosphate (PPi) is a potent inhibitor of calcification and 
AP has been identified as one of the central regulators of 
mineralization via its ability to control the pool of extracellular 
PPi, (i.e., PPi that is generated, or transported to the outside 
of the cells). Previous studies have reported that the major 
role for TNAP in bone tissue is hydrolysis of PPi to maintain 
proper levels of this inhibitor of mineralization, thus ensuring 
normal bone mineralization (Hessle et al., 2002; Johnson et 
al., 2003). Another recognized function of AP is its role as a 
lipopolysaccharide (LPS)-detoxifying enzyme. This function 
of AP was first established by Poelstra et al. (1997). LPS 
plays a major role in the development and/or aggravation of 
several multifactoral diseases, including sepsis, 
atherosclerosis, inflammatory bowel disease (IBD), 
rheumatoid arthritis (RA), and multiple sclerosis (MS) 
(Vincent et al., 1992; Patel et al., 1995). The toxic moiety of 
lipopolysaccharide is the well-preserved Lipid A part. Lipid A 
contains two phosphate groups attached to two glucosamine 
which determine the toxicity level and are crucial for the 
biological activities of LPS. AP catalyses the enzymatic 
removal of phosphate groups from LPS, thereby detoxifying it 
(Poelstra et al., 1997; Bentala et al., 2002).  
Quite a number of substrate and transition state analogue 
inhibitors of AP have been studied. AP is inhibited by several 
compounds on the basis of different mechanisms. L-
phenylalanine, imidazole, histamine and theophylline are 
known to inhibit alkaline phosphatase uncompetitively while 
phosphate, phosphoethanolamine and phenylphosphonate 
are competitive inhibitors (Ghosh and Fishman, 1966; Farley 
et al., 1987; Hoylaerts et al., 1992). Vanadate is known to 
markedly inhibit intestinal, placental, and renal isoenzyme 
(Chen and Zhou, 1999; Cuncic et al., 1999) by competitive 
inhibition mechanism (Tromp et al., 1991) or mixed inhibition 
mechanism (Shirazi et al., 1981; Malomo et al., 2003). 
Vanadate and L-phenylalanine have been shown to display 
positive synergistic interactions in their inhibition of rat liver 
alkaline phosphatase (Malomo et al., 2003).  
In earlier reports, we showed that optimal concentrations of 
Mg2+ and Zn2+ activated CIAP catalysed hydrolysis of para-
nitrophenyl phosphate (pNPP) (monoesterase reaction) 
(Olorunniji et al., 2007; Igunnu et al., 2011). In view of the 
biological functions of alkaline phosphatase, the mechanistic 
details of the interaction between the metal cofactors and 
inhibitors are important to our understanding of how AP 
inhibition is modulated in the body. Thus, the effects of Mg2+ 
and Zn2+ on vanadate-inhibited monoesterase activity of calf 
intestinal AP (CIAP) were investigated in this study with a 
view to gaining understanding of the interaction between the 
metal ions and vanadate in AP catalysis. The mechanistic 
details and the implication of how the metal cofactors 
modulated the extent of inhibition of CIAP by vanadate are 
herein discussed. 
MATERIALS AND METHODS 
Materials 
Alkaline phosphatase substrate, the sodium salt of para-
nitrophenyl phosphate (pNPP), was obtained from Sigma-
Aldrich, UK. Magnesium chloride (MgCl2), zinc chloride 
(ZnCl2) and sodium orthovanadate were obtained from Fisher 
Scientific, UK. All other chemicals used in this study were of 
analytical grade. Purified homogenous CIAP was obtained 
from New England Biolabs, UK.  
Preparation of Dialyzed CIAP 
Loosely bound metal ions were removed from CIAP 
according to the method of Koutsoulis et al. (2010). A 500 µl 
sample of 28 µM CIAP was dialysed in 20 mM Tris-HCl (pH 
7.6) at 4 oC for 24 hours. 
CIAP-Catalyzed Hydrolysis of pNPP 
Monoesterase activity of CIAP was measured by the rate of 
hydrolysis of pNPP in the presence of catalytic cofactors 
(Zn2+ and Mg2+) and vanadate at 37 ºC in 50 mM Tris-HCl 
(pH 8.5). Details of each experiment are described in the 
Figure Legends. Reaction mixtures containing 10 µM CIAP 
and 50 mM Tris-HCl (pH 8.5) was pre-incubated at 37 oC with 
vanadate for 10 minutes and reactions were initiated by the 
addition of appropriate concentration of pNPP in the 
presence of catalytic cofactors. Reactions were carried out 
for 10 minutes at 37 oC, and stopped by the addition of 500 
mM NaOH and 10 mM EDTA. The absorbance was read at 
405 nm against a blank of the buffered substrate. 
Spectrophotometric readings were taking in a Perkin Elmer 
Lambda 45 UV/VIS instrument. Activities are expressed as 
change in A405 per minute reflecting the release of p-
nitrophenol from the substrate p-nitrophenylphosphate 
(pNPP). Curve fitting was carried out using GraphPad Prism 
4.0 (2005). 





In order to test the effect of cofactors on the activity of CIAP 
and its inhibition by vanadate, it was necessary to prepare 
enzyme samples that are significantly free of the two metal 
ion cofactors (Zn2+ and Mg2+). Preparation of the ‘cofactor-
free’ CIAP was done by extensively dialyzing the enzyme in a 
low ionic strength buffer (Koutsoulis et al. 2010). It has been 
shown that this procedure efficiently strips the enzyme of any 
loosely bound metal ions. These demetalated enzyme 
preparations were used for subsequent experiments 
designed to test the interaction of cofactors and vanadate 
during CIAP-catalysed hydrolysis of pNPP. 
The effect of catalytic cofactors (Mg2+ and Zn2+) on the 
inhibition of CIAP by vanadate is shown in Figure 1. 
Vanadate significantly inhibited dialyzed CIAP but its effect 
was modulated significantly by the addition of the catalytic 
cofactors. However, the activity of the enzyme in the 
presence of both vanadate and catalytic cofactors was 
significantly lower than in their absence.  
Figure 2 shows the effect of catalytic cofactors (Mg2+ and 
Zn2+) and vanadate on substrate kinetics of CIAP-catalyzed 
hydrolysis of pNPP. ). The results showed that vanadate 
significantly inhibited ʻcofactor-freeʼ CIAP, and the inhibition 
was relieved by the presence of the catalytic cofactors in the 
reaction. Our results show that the absence of the cofactors 
did not significantly alter the Km of the reaction, but caused a 
decrease in the Vmax. Kinetic analyses showed that 
vanadate inhibited CIAP-catalyzed hydrolysis of pNPP by 




The presence of cofactors in the reaction alleviated the effect 
of vanadate by increasing the Vmax and decreasing the Km. 
The activity of the dialyzed CIAP was increased by the 
addition of catalytic cofactors to vanadate-inhibited enzyme 
The effect of increasing concentration of vanadate on CIAP 
activity in the presence and absence of catalytic cofactors 
(Mg2+ and Zn2+) is shown in Figure 3. The activity of the 
dialyzed CIAP was increased by the addition of catalytic 
cofactors to vanadate-inhibited enzyme.  
 
DISCUSSION  
Metal ions are essential to life and a major determinant of 
their functional relevance in living systems is that a 
substantial fraction of enzymes require metals for their 
catalytic activity (Andreini et al., 2008). Magnesium is the 
most widespread metal present in enzymes. The main 
reason behind this observation is that magnesium plays a 
central role as the essential partner of phosphate-containing 
substrates which in cells is largely present as Mg2+ complex 
(Luthi et al., 1999). The association between Mg2+ and 
phosphate is in fact a constant feature of key biological 
molecules (e.g. DNA, RNA), suggesting that biological 
systems have selected the abundant and highly soluble Mg2+ 
since the early stages of life (Andreini et al., 2008). Recent 
evidence suggests that the Mg2+ in the active site of alkaline 
phosphatase stabilizes the transferred phosphoryl group via 
a water molecule and functions via a mechanism different 
Figure 1: The effect of catalytic cofactors (Mg2+ and Zn2+) on the inhibition of CIAP by vanadate. Reactions mixtures 
containing 50 mM Tris-HCl (pH 8.5) and 10 µM CIAP was pre-incubated at 37 oC with vanadate for 10 minutes and 
reactions were initiated by the addition of 400 µM pNPP. Reactions were carried out for 10 minutes at 37 oC, and 
stopped by the addition of 500 mM NaOH and 10 mM EDTA. Enzyme activity is expressed as the change in A405 per 
minute. Each bar represents the mean ± SD of five individual reactions. 
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from the two Zn2+ ions at the bimetallocentre (Zalatan et al., 
2008). Zinc is the second-most abundant metal ion in 
enzymes. The reason for the high occurrence of zinc in 
enzyme catalysis lies in the distinctive combination of 
properties displayed by this metal. From one point of view, 
zinc resembles the group II elements in that it is also stable 
in the +2 oxidation state, and is redox inert. In particular, the 
Zn2+ has a radius (0.74 Å) similar to that of Mg2+ and the 
electrostatic binding to negatively charged species, accounts 
for part of zinc functionality in the active site of enzymes 
(Andreini et al., 2008). Zn2+ is known to perform this function 
in a variety of enzymes such as alkaline phosphatase, 
containing dinuclear zinc sites, in which one of the ions 
contribute to activate water, which bridges the two metals, 
and the other ion is involved in substrate binding and 





The inhibition by vanadate has been hypothesized to be 
more potent in enzymes involving a stable covalent 
phosphoryl enzyme intermediate than those in which the 
product is formed without covalent involvement of the 
enzyme. It is particularly active against Na+/K+ ATPase, 
human AP and E. coli AP (Cyboron et al., 1982). The results 
obtained in this study suggest that vanadate is an active site 
inhibitor which exerted its inhibitory effect on the dialyzed 
CIAP via a mechanism that decrease the binding affinity of 
the enzyme for pNPP. This observation corroborated the 
report of Stankiewicz et al. (1995) that ascribed the inhibitory 
effect of vanadate on phosphate-metabolizing enzymes to its 
ability to mimic the anionic character of inorganic phosphate 









Figure 2: The effect of catalytic cofactors (Mg2+ and Zn2+) and vanadate on substrate kinetics of CIAP 
catalyzed hydrolysis of pNPP. Reactions were carried out as described in Figure 1. The concentrations of 
pNPP used were 20, 50, 100, 200, 400, and 800 µM. The kinetic parameters Km and Vmax estimated from the 
curves are shown in the lower panel. The curves represent the mean of three separate sets of experiments. 
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It is apparent from this study that the addition of catalytic 
cofactors (Mg2+ and Zn2+) modulated vanadate inhibition of 
CIAP-catalysed hydrolysis of pNPP by increasing the 
enzymeʼs turnover rate and binding affinity for its substrate. 
Subramaniam et al. (1995) described that Mg2+ plays an 
important role as a site-specific effector since it binds to the 
non-native structure, probably to the active site region of the 
enzyme, stabilizing transient conformations and guiding 
conformational reconstitution into productive pathways. Also, 
previous studies have shown that Zn2+ binding to TNAP are 
required for both catalysis and thermodynamic stability while 
Mg2+ enhances both characteristics (Coleman, 1992). One of 
the two Zn2+ ions in each monomer of the enzyme is involved 
in binding the substrate in AP catalysis (Kim and Wyckoff, 
1991; Bortolato et al., 1999). The relieve of vanadate 
inhibition of CIAP-catalyzed hydrolysis of pNPP by the 
catalytic cofactors as observed in this study also 
corroborates the report of Dirnbach et al. (2001) that the 
binding of one Mg2+ per enzyme dimer appears to cause a 
slight slowing down of the guanidine hydrochloride 
denaturation reaction; however, two bound Mg2+ ions have a 
dramatic protection effect. They also noted that just as Zn2+ 
provides AP with substantial thermodynamic stability, Mg2+ 
provides kinetic stability, slowing down the unfolding of AP 
under hostile, denaturing conditions. The results from this 
study reveal that vanadate inhibition of CIAP-catalyzed 
hydrolysis of pNPP can be relieved by the addition of 
catalytic cofactors. Further mechanistic studies could provide  
 
More insight into how inhibited AP can be reactivated which 
may be of significance in the biological system.  
These findings also hint that the pattern of reversible 
inhibition of cofactor-requiring enzymes could be subject to 
the accessibility of the apoenzymes to the catalytic cofactors. 
Further studies will reveal detailed mechanistic aspects of 
this observation and its significance in natural  biological 
systems.  
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